ATE209034T1 - Taxolderivate - Google Patents
TaxolderivateInfo
- Publication number
- ATE209034T1 ATE209034T1 AT94921511T AT94921511T ATE209034T1 AT E209034 T1 ATE209034 T1 AT E209034T1 AT 94921511 T AT94921511 T AT 94921511T AT 94921511 T AT94921511 T AT 94921511T AT E209034 T1 ATE209034 T1 AT E209034T1
- Authority
- AT
- Austria
- Prior art keywords
- taxol derivatives
- formula
- taxol
- ch2opo3
- ch2oso3
- Prior art date
Links
- 150000004579 taxol derivatives Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 229930012538 Paclitaxel Natural products 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 229960001592 paclitaxel Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 abstract 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Epoxy Compounds (AREA)
- Medicinal Preparation (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/092,124 US5468769A (en) | 1993-07-15 | 1993-07-15 | Paclitaxel derivatives |
| PCT/US1994/007973 WO1995002400A1 (en) | 1993-07-15 | 1994-07-15 | Taxol derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE209034T1 true ATE209034T1 (de) | 2001-12-15 |
Family
ID=22231738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94921511T ATE209034T1 (de) | 1993-07-15 | 1994-07-15 | Taxolderivate |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5468769A (de) |
| EP (1) | EP0708642B1 (de) |
| JP (1) | JPH09500138A (de) |
| AT (1) | ATE209034T1 (de) |
| CA (1) | CA2165079A1 (de) |
| DE (1) | DE69429173T2 (de) |
| ES (1) | ES2168304T3 (de) |
| WO (1) | WO1995002400A1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5990325A (en) | 1993-03-05 | 1999-11-23 | Florida State University | Process for the preparation of 9-desoxotaxol, 9-desoxobaccatin III and analogs thereof |
| US5973160A (en) | 1992-12-23 | 1999-10-26 | Poss; Michael A. | Methods for the preparation of novel sidechain-bearing taxanes |
| EP1155689B1 (de) | 1993-07-19 | 2006-09-20 | Angiotech Pharmaceuticals, Inc. | Anti-angiogener Stent und Verfahren zu dessen Herstellung |
| US5965566A (en) * | 1993-10-20 | 1999-10-12 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
| US6441025B2 (en) * | 1996-03-12 | 2002-08-27 | Pg-Txl Company, L.P. | Water soluble paclitaxel derivatives |
| DE69735057T2 (de) | 1996-03-12 | 2006-08-31 | PG-TXL Co., L.P., Houston | Wasserlösliche paclitaxel-prodrogen |
| US5635531A (en) * | 1996-07-08 | 1997-06-03 | Bristol-Myers Squibb Company | 3'-aminocarbonyloxy paclitaxels |
| AU4768797A (en) | 1996-10-24 | 1998-05-15 | Institute Armand-Frappier | A family of canadensol taxanes, the semi-synthetic preparation and therapeutic use thereof |
| US6458373B1 (en) * | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
| US20020077290A1 (en) * | 2000-03-17 | 2002-06-20 | Rama Bhatt | Polyglutamic acid-camptothecin conjugates and methods of preparation |
| HUP0302599A3 (en) | 2000-09-22 | 2005-05-30 | Bristol Myers Squibb Co | Method for reducing toxicity of combined chemotherapic compositions |
| CA2426762A1 (en) | 2000-11-02 | 2002-05-10 | Sloan-Kettering Institute For Cancer Research | Methods for enhancing the efficacy of cytotoxic agents through the use of hsp90 inhibitors |
| JP2006513152A (ja) * | 2002-10-09 | 2006-04-20 | ファイトジェン ライフ サイエンシズ インコーポレイテッド | 新規タキサンならびにその使用および調製に関する方法 |
| US8088737B2 (en) | 2003-04-04 | 2012-01-03 | Incyte Corporation | Compositions, methods and kits relating to Her-2 cleavage |
| US7202370B2 (en) * | 2003-10-27 | 2007-04-10 | Conor Medsystems, Inc. | Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III |
| USH2260H1 (en) | 2005-02-17 | 2011-07-05 | Angiotech International Ag | Stents combined with paclitaxel derivatives |
| CN101611007A (zh) | 2006-12-20 | 2009-12-23 | 先灵公司 | 新颖的jnk抑制剂 |
| JP2013506669A (ja) | 2009-09-30 | 2013-02-28 | メルク・シャープ・アンド・ドーム・コーポレーション | Erk阻害剤である新規化合物 |
| CA2811990C (en) | 2010-08-23 | 2023-03-21 | Dean Y. Maeda | Aminopyridine- and aminopyrimidinecarboxamides as cxcr2 modulators |
| US8969365B2 (en) | 2013-08-02 | 2015-03-03 | Syntrix Biosystems, Inc. | Thiopyrimidinecarboxamides as CXCR1/2 modulators |
| EP3027627B1 (de) | 2013-08-02 | 2018-01-31 | Syntrix Biosystems Inc. | 2-[5-[n-(4-fluorophenyl)carbamoyl]pyrimidin-2-ylsulfanylmethyl]-4-(trifluoromethoxy)phenyl]bor saure |
| US10561676B2 (en) | 2013-08-02 | 2020-02-18 | Syntrix Biosystems Inc. | Method for treating cancer using dual antagonists of CXCR1 and CXCR2 |
| US10046002B2 (en) | 2013-08-02 | 2018-08-14 | Syntrix Biosystems Inc. | Method for treating cancer using chemokine antagonists |
| BR112022004851A2 (pt) | 2019-09-19 | 2022-08-23 | Leap Therapeutics Inc | Uso de inibidores de dkk-1 para tratar câncer |
| EP4061419A1 (de) | 2019-11-22 | 2022-09-28 | Leap Therapeutics, Inc. | Methoden zum behandeln von krebs mit dkk-1-hemmern |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4942184A (en) * | 1988-03-07 | 1990-07-17 | The United States Of America As Represented By The Department Of Health And Human Services | Water soluble, antineoplastic derivatives of taxol |
| JPH07505887A (ja) * | 1992-04-17 | 1995-06-29 | アボツト・ラボラトリーズ | タキソール誘導体 |
-
1993
- 1993-07-15 US US08/092,124 patent/US5468769A/en not_active Expired - Fee Related
-
1994
- 1994-07-15 ES ES94921511T patent/ES2168304T3/es not_active Expired - Lifetime
- 1994-07-15 JP JP7504746A patent/JPH09500138A/ja not_active Withdrawn
- 1994-07-15 AT AT94921511T patent/ATE209034T1/de not_active IP Right Cessation
- 1994-07-15 DE DE69429173T patent/DE69429173T2/de not_active Expired - Fee Related
- 1994-07-15 WO PCT/US1994/007973 patent/WO1995002400A1/en not_active Ceased
- 1994-07-15 EP EP94921511A patent/EP0708642B1/de not_active Expired - Lifetime
- 1994-07-15 CA CA002165079A patent/CA2165079A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0708642A1 (de) | 1996-05-01 |
| DE69429173T2 (de) | 2002-07-04 |
| EP0708642A4 (de) | 1996-03-12 |
| CA2165079A1 (en) | 1995-01-26 |
| EP0708642B1 (de) | 2001-11-21 |
| JPH09500138A (ja) | 1997-01-07 |
| DE69429173D1 (en) | 2002-01-03 |
| ES2168304T3 (es) | 2002-06-16 |
| US5468769A (en) | 1995-11-21 |
| WO1995002400A1 (en) | 1995-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE209034T1 (de) | Taxolderivate | |
| AU1608692A (en) | Amidinophenylalanine derivatives, a process for the preparation thereof, use thereof and agents containing these as anticoagulants | |
| RU2088589C1 (en) | Derivatives of 17 beta-substituted-4-aza-5-5 alpha-androstane-3-ones, methods of synthesis of compounds, pharmaceutical composition, compound 4 | |
| SE9203825L (sv) | Dubbelt verkande inhibitorer foer no-syntas och cyklooxygenas, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma | |
| MX9204029A (es) | Procedimiento de preparacion de un derivado de la bacatina iii y de la 10-desacetil bacatina iii | |
| HUT61555A (en) | Process for producing 2,8-dioxa-bicyclo/3.2.1/octane derivatives and pharmaceutical compositions comprising same | |
| DE69213546D1 (de) | Neue Peptid-Verbindungen und Verfahren zur Herstellung davon | |
| ATE201671T1 (de) | Chinolon und acridinon derivate zur behandlung der harninkontinenz | |
| FI935800A0 (fi) | Antidepressiva och mot Parkisons sjukdom verksamma foereningar | |
| KR960703863A (ko) | 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer) | |
| ATE344230T1 (de) | Triphenylbutenderivate zur behandlung von neurologischen störungen | |
| DE69330601D1 (de) | Serotoninergische ergolin derivate | |
| IL108665A (en) | Pharmaceutical compositions containing ureido derivatives of substituted pyrroles, certain such novel compounds and their preparation | |
| CA2030732A1 (fr) | Nouveaux derives du thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant | |
| HUT70761A (en) | Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof | |
| SE8304410D0 (sv) | Cyklohexylkarboxylsyraderivat och sett for deras framstellning | |
| ATE149159T1 (de) | Heteroarylmethylbenzole-aromatasehemmer | |
| SE9203824L (sv) | Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma | |
| ATE100463T1 (de) | Renin-hemmende aminooligohydroxy-derivate. | |
| ES8201993A1 (es) | Un procedimiento para la preparacion de tiazoles | |
| AU577159B2 (en) | Morpholinoethylamino-1,3,4-thiadiazole compounds | |
| ES528459A0 (es) | Procedimiento de preparacion de nuevos derivados 1-hidroxipropil resorcinos provistos de un grupo fenilo sustituidos. | |
| SE8903313L (sv) | Nya 2-metoxikarbonyl-substituerade n,n'-di-(trimetoxibensoyl)-piperaziner, foerfarande foer framstaellning daerav och terapeutiska foereningar innehaallande dem | |
| DE69528984D1 (de) | Hemmung der leukotrienbiosynthese mittels harnstoffderivaten | |
| ES2079997A1 (es) | Compuestos de fenil fenol sustituidos antagonistas de leucotrieno, procedimiento para su obtencion y formulaciones farmaceuticas de los mismos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |